After 2 yrs of serious adverse reactions she now has T-cell lymphoma

Olivia Teseniar who was part of Moderna’s trial recorded her last meeting with the Principal Investigator of the trial. (2 minutes, 19 seconds)
After 2 yrs of serious adverse reactions she now has T-cell lymphoma and leukaemia. Her issues were omitted from Moderna’s submission to the FDA.